Cargando…
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
BACKGROUND: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen se...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726888/ https://www.ncbi.nlm.nih.gov/pubmed/33298191 http://dx.doi.org/10.1186/s13601-020-00342-x |
| _version_ | 1783620972584108032 |
|---|---|
| author | Bédard, A. Basagaña, X. Anto, J. M. Garcia-Aymerich, J. Devillier, P. Arnavielhe, S. Bedbrook, A. Onorato, G. L. Czarlewski, W. Murray, R. Almeida, R. Fonseca, J. A. Correia da Sousa, J. Costa, E. Morais-Almeida, M. Todo-Bom, A. Cecchi, L. De Feo, G. Illario, M. Menditto, E. Monti, R. Stellato, C. Ventura, M. T. Annesi-Maesano, I. Bosse, I. Fontaine, J. F. Pham-Thi, N. Thibaudon, M. Schmid-Grendelmeier, P. Spertini, F. Chavannes, N. H. Fokkens, W. J. Reitsma, S. Dubakiene, R. Emuzyte, R. Kvedariene, V. Valiulis, A. Kuna, P. Samolinski, B. Klimek, L. Mösges, R. Pfaar, O. Shamai, S. Roller-Wirnsberger, R. E. Tomazic, P. V. Ryan, D. Sheikh, A. Haahtela, T. Toppila-Salmi, S. Valovirta, E. Cardona, V. Mullol, J. Valero, A. Makris, M. Papadopoulos, N. G. Prokopakis, E. P. Psarros, F. Bachert, C. Hellings, P. W. Pugin, B. Bindslev-Jensen, C. Eller, E. Kull, I. Melén, E. Wickman, M. De Vries, G. van Eerd, M. Agache, I. Ansotegui, I. J. Bosnic-Anticevich, S. Cruz, A. A. Casale, T. Ivancevich, J. C. Larenas-Linnemann, D. E. Sofiev, M. Wallace, D. Waserman, S. Yorgancioglu, A. Laune, D. Bousquet, J. |
| author_facet | Bédard, A. Basagaña, X. Anto, J. M. Garcia-Aymerich, J. Devillier, P. Arnavielhe, S. Bedbrook, A. Onorato, G. L. Czarlewski, W. Murray, R. Almeida, R. Fonseca, J. A. Correia da Sousa, J. Costa, E. Morais-Almeida, M. Todo-Bom, A. Cecchi, L. De Feo, G. Illario, M. Menditto, E. Monti, R. Stellato, C. Ventura, M. T. Annesi-Maesano, I. Bosse, I. Fontaine, J. F. Pham-Thi, N. Thibaudon, M. Schmid-Grendelmeier, P. Spertini, F. Chavannes, N. H. Fokkens, W. J. Reitsma, S. Dubakiene, R. Emuzyte, R. Kvedariene, V. Valiulis, A. Kuna, P. Samolinski, B. Klimek, L. Mösges, R. Pfaar, O. Shamai, S. Roller-Wirnsberger, R. E. Tomazic, P. V. Ryan, D. Sheikh, A. Haahtela, T. Toppila-Salmi, S. Valovirta, E. Cardona, V. Mullol, J. Valero, A. Makris, M. Papadopoulos, N. G. Prokopakis, E. P. Psarros, F. Bachert, C. Hellings, P. W. Pugin, B. Bindslev-Jensen, C. Eller, E. Kull, I. Melén, E. Wickman, M. De Vries, G. van Eerd, M. Agache, I. Ansotegui, I. J. Bosnic-Anticevich, S. Cruz, A. A. Casale, T. Ivancevich, J. C. Larenas-Linnemann, D. E. Sofiev, M. Wallace, D. Waserman, S. Yorgancioglu, A. Laune, D. Bousquet, J. |
| author_sort | Bédard, A. |
| collection | PubMed |
| description | BACKGROUND: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users. METHODS: The Allergy Diary–MASK-air–mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis. RESULTS: 9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines. CONCLUSIONS: This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year. |
| format | Online Article Text |
| id | pubmed-7726888 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77268882020-12-10 Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study Bédard, A. Basagaña, X. Anto, J. M. Garcia-Aymerich, J. Devillier, P. Arnavielhe, S. Bedbrook, A. Onorato, G. L. Czarlewski, W. Murray, R. Almeida, R. Fonseca, J. A. Correia da Sousa, J. Costa, E. Morais-Almeida, M. Todo-Bom, A. Cecchi, L. De Feo, G. Illario, M. Menditto, E. Monti, R. Stellato, C. Ventura, M. T. Annesi-Maesano, I. Bosse, I. Fontaine, J. F. Pham-Thi, N. Thibaudon, M. Schmid-Grendelmeier, P. Spertini, F. Chavannes, N. H. Fokkens, W. J. Reitsma, S. Dubakiene, R. Emuzyte, R. Kvedariene, V. Valiulis, A. Kuna, P. Samolinski, B. Klimek, L. Mösges, R. Pfaar, O. Shamai, S. Roller-Wirnsberger, R. E. Tomazic, P. V. Ryan, D. Sheikh, A. Haahtela, T. Toppila-Salmi, S. Valovirta, E. Cardona, V. Mullol, J. Valero, A. Makris, M. Papadopoulos, N. G. Prokopakis, E. P. Psarros, F. Bachert, C. Hellings, P. W. Pugin, B. Bindslev-Jensen, C. Eller, E. Kull, I. Melén, E. Wickman, M. De Vries, G. van Eerd, M. Agache, I. Ansotegui, I. J. Bosnic-Anticevich, S. Cruz, A. A. Casale, T. Ivancevich, J. C. Larenas-Linnemann, D. E. Sofiev, M. Wallace, D. Waserman, S. Yorgancioglu, A. Laune, D. Bousquet, J. Clin Transl Allergy Review BACKGROUND: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users. METHODS: The Allergy Diary–MASK-air–mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis. RESULTS: 9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines. CONCLUSIONS: This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year. BioMed Central 2020-12-09 /pmc/articles/PMC7726888/ /pubmed/33298191 http://dx.doi.org/10.1186/s13601-020-00342-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Review Bédard, A. Basagaña, X. Anto, J. M. Garcia-Aymerich, J. Devillier, P. Arnavielhe, S. Bedbrook, A. Onorato, G. L. Czarlewski, W. Murray, R. Almeida, R. Fonseca, J. A. Correia da Sousa, J. Costa, E. Morais-Almeida, M. Todo-Bom, A. Cecchi, L. De Feo, G. Illario, M. Menditto, E. Monti, R. Stellato, C. Ventura, M. T. Annesi-Maesano, I. Bosse, I. Fontaine, J. F. Pham-Thi, N. Thibaudon, M. Schmid-Grendelmeier, P. Spertini, F. Chavannes, N. H. Fokkens, W. J. Reitsma, S. Dubakiene, R. Emuzyte, R. Kvedariene, V. Valiulis, A. Kuna, P. Samolinski, B. Klimek, L. Mösges, R. Pfaar, O. Shamai, S. Roller-Wirnsberger, R. E. Tomazic, P. V. Ryan, D. Sheikh, A. Haahtela, T. Toppila-Salmi, S. Valovirta, E. Cardona, V. Mullol, J. Valero, A. Makris, M. Papadopoulos, N. G. Prokopakis, E. P. Psarros, F. Bachert, C. Hellings, P. W. Pugin, B. Bindslev-Jensen, C. Eller, E. Kull, I. Melén, E. Wickman, M. De Vries, G. van Eerd, M. Agache, I. Ansotegui, I. J. Bosnic-Anticevich, S. Cruz, A. A. Casale, T. Ivancevich, J. C. Larenas-Linnemann, D. E. Sofiev, M. Wallace, D. Waserman, S. Yorgancioglu, A. Laune, D. Bousquet, J. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study |
| title | Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study |
| title_full | Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study |
| title_fullStr | Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study |
| title_full_unstemmed | Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study |
| title_short | Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study |
| title_sort | treatment of allergic rhinitis during and outside the pollen season using mobile technology. a mask study |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726888/ https://www.ncbi.nlm.nih.gov/pubmed/33298191 http://dx.doi.org/10.1186/s13601-020-00342-x |
| work_keys_str_mv | AT bedarda treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT basaganax treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT antojm treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT garciaaymerichj treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT devillierp treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT arnavielhes treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT bedbrooka treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT onoratogl treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT czarlewskiw treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT murrayr treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT almeidar treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT fonsecaja treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT correiadasousaj treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT costae treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT moraisalmeidam treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT todoboma treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT cecchil treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT defeog treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT illariom treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT mendittoe treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT montir treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT stellatoc treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT venturamt treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT annesimaesanoi treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT bossei treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT fontainejf treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT phamthin treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT thibaudonm treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT schmidgrendelmeierp treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT spertinif treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT chavannesnh treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT fokkenswj treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT reitsmas treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT dubakiener treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT emuzyter treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT kvedarienev treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT valiulisa treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT kunap treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT samolinskib treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT klimekl treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT mosgesr treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT pfaaro treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT shamais treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT rollerwirnsbergerre treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT tomazicpv treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT ryand treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT sheikha treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT haahtelat treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT toppilasalmis treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT valovirtae treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT cardonav treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT mullolj treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT valeroa treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT makrism treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT papadopoulosng treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT prokopakisep treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT psarrosf treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT bachertc treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT hellingspw treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT puginb treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT bindslevjensenc treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT ellere treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT kulli treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT melene treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT wickmanm treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT devriesg treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT vaneerdm treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT agachei treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT ansoteguiij treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT bosnicanticevichs treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT cruzaa treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT casalet treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT ivancevichjc treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT larenaslinnemannde treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT sofievm treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT wallaced treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT wasermans treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT yorgancioglua treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT launed treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT bousquetj treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy AT treatmentofallergicrhinitisduringandoutsidethepollenseasonusingmobiletechnologyamaskstudy |